[PDF] academia.edu

[PDF][PDF] The management of pulmonary fibrosis in COVID-19

CM Rumende, EC Susanto, TP Sitorus - academia.edu
Pulmonary fibrosis due to COVID-19 is recognized as sequel of ARDS characterized by
failed alveolar reepithelization, fibroblast activation, excessive collagen deposition and other …
被引用次数：26 相关文章

The Management of Pulmonary Fibrosis in COVID-19.

CM Rumende, EC Susanto, TP Sitorus - Acta Medica Indonesiana, 2021 - europepmc.org
Pulmonary fibrosis due to COVID-19 is recognized as sequel of ARDS characterized by
failed alveolar re-epithelization, fibroblast activation, excessive collagen deposition and …

The Management of Pulmonary Fibrosis in COVID-19

CM Rumende, EC Susanto… - Acta medica …, 2021 - pubmed.ncbi.nlm.nih.gov
Pulmonary fibrosis due to COVID-19 is recognized as sequel of ARDS characterized by
failed alveolar re-epithelization, fibroblast activation, excessive collagen deposition and …

The Management of Pulmonary Fibrosis in COVID-19

CM Rumende, EC Susanto… - Acta Medica …, 2021 - actamedindones.org
Pulmonary fibrosis due to COVID-19 is recognized as sequel of ARDS characterized by
failed alveolar re-epithelization, fibroblast activation, excessive collagen deposition and …

The Management of Pulmonary Fibrosis in COVID-19

CM Rumende, EC Susanto… - Acta Medica …, 2021 - actamedindones.org
Pulmonary fibrosis due to COVID-19 is recognized as sequel of ARDS characterized by
failed alveolar re-epithelization, fibroblast activation, excessive collagen deposition and …

The Management of Pulmonary Fibrosis in COVID-19

CM Rumende, EC Susanto, TP Sitorus - Acta medica Indonesiana, 2021 - scholar.ui.ac.id
Pulmonary fibrosis due to COVID-19 is recognized as sequel of ARDS characterized by
failed alveolar re-epithelization, fibroblast activation, excessive collagen deposition and …